{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:30Z","timestamp":1787032890024,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,27]]},"DOI":"10.7759\/cureus.70321","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T08:48:48Z","timestamp":1727426928000},"source":"Crossref","is-referenced-by-count":1,"title":["Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab"],"prefix":"10.7759","author":[{"given":"Kazuki","family":"Yatsuzuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Kidani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamoto","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2020.03.003","article-title":"Palmoplantar pustulosis: current understanding of disease definition and pathomechanism","volume":"98","author":"Murakami M","year":"2020","unstructured":"Murakami M, Terui T. Palmoplantar pustulosis: current understanding of disease definition and pathomechanism. J Dermatol Sci. 2020, 98:13-9. 10.1016\/j.jdermsci.2020.03.003","journal-title":"J Dermatol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2011.01325.x","article-title":"Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum","volume":"20","author":"Murakami M","year":"2011","unstructured":"Murakami M, Hagforsen E, Morhenn V, Ishida-Yamamoto A, Iizuka H. Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum. Exp Dermatol. 2011, 20:845-7. 10.1111\/j.1600-0625.2011.01325.x","journal-title":"Exp Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2021.03.004","article-title":"New fluorescent three-dimensional and deep-imaging technique confirms a direct relationship between the acrosyringium and vesicles\/pustules of palmoplantar pustulosis","volume":"102","author":"Murakami M","year":"2021","unstructured":"Murakami M, Kawakami R, Niko Y, et al.. New fluorescent three-dimensional and deep-imaging technique confirms a direct relationship between the acrosyringium and vesicles\/pustules of palmoplantar pustulosis. J Dermatol Sci. 2021, 102:130-2. 10.1016\/j.jdermsci.2021.03.004","journal-title":"J Dermatol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50875-x","article-title":"A fluorescence imaging technique suggests that sweat leakage in the epidermis contributes to the pathomechanism of palmoplantar pustulosis","volume":"14","author":"Yatsuzuka K","year":"2024","unstructured":"Yatsuzuka K, Kawakami R, Niko Y, et al.. A fluorescence imaging technique suggests that sweat leakage in the epidermis contributes to the pathomechanism of palmoplantar pustulosis. Sci Rep. 2024, 14:378. 10.1038\/s41598-023-50875-x","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-018-00745-6","article-title":"Clinical characteristics of Japanese patients with palmoplantar pustulosis","volume":"39","author":"Yamamoto T","year":"2019","unstructured":"Yamamoto T. Clinical characteristics of Japanese patients with palmoplantar pustulosis. Clin Drug Investig. 2019, 39:241-52. 10.1007\/s40261-018-00745-6","journal-title":"Clin Drug Investig"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02934-3","article-title":"Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes","volume":"24","author":"Ueno M","year":"2022","unstructured":"Ueno M, Miyagawa I, Miyazaki Y, et al.. Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes. Arthritis Res Ther. 2022, 24:240. 10.1186\/s13075-022-02934-3","journal-title":"Arthritis Res Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0729","article-title":"Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study","volume":"164","author":"Cleynen I","year":"2016","unstructured":"Cleynen I, Van Moerkercke W, Billiet T, et al.. Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study. Ann Intern Med. 2016, 164:10-22. 10.7326\/M15-0729","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.12.010","article-title":"Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis","volume":"86","author":"Murphy MJ","year":"2022","unstructured":"Murphy MJ, Cohen JM, Vesely MD, Damsky W. Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis. J Am Acad Dermatol. 2022, 86:1080-91. 10.1016\/j.jaad.2020.12.010","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16103","article-title":"Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center","volume":"48","author":"Mori M","year":"2021","unstructured":"Mori M, Tobita R, Egusa C, et al.. Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center. J Dermatol. 2021, 48:1745-53. 10.1111\/1346-8138.16103","journal-title":"J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071485","article-title":"Pathogenesis of paradoxical reactions associated with targeted biologic agents for inflammatory skin diseases","volume":"10","author":"Miyagawa F","year":"2022","unstructured":"Miyagawa F. Pathogenesis of paradoxical reactions associated with targeted biologic agents for inflammatory skin diseases. Biomedicines. 2022, 10:1485. 10.3390\/biomedicines10071485","journal-title":"Biomedicines"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4083-5","article-title":"Paradoxical skin lesions induced by anti-TNF-\u03b1 agents in SAPHO syndrome","volume":"38","author":"Li C","year":"2019","unstructured":"Li C, Wu X, Cao Y, et al.. Paradoxical skin lesions induced by anti-TNF-\u03b1 agents in SAPHO syndrome. Clin Rheumatol. 2019, 38:53-61. 10.1007\/s10067-018-4083-5","journal-title":"Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16355","article-title":"Efficacy of guselkumab in a subpopulation with pustulotic arthro-osteitis through week 52: an exploratory analysis of a phase 3, randomized, double-blind, placebo-controlled study in Japanese patients with palmoplantar pustulosis","volume":"34","author":"Yamamoto T","year":"2020","unstructured":"Yamamoto T, Fukuda K, Morita A, et al.. Efficacy of guselkumab in a subpopulation with pustulotic arthro-osteitis through week 52: an exploratory analysis of a phase 3, randomized, double-blind, placebo-controlled study in Japanese patients with palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2020, 34:2318-29. 10.1111\/jdv.16355","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/298075-successful-treatment-of-adalimumab-induced-paradoxical-skin-reactions-in-pustulotic-arthro-osteitis-with-guselkumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T08:48:49Z","timestamp":1727426929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/298075-successful-treatment-of-adalimumab-induced-paradoxical-skin-reactions-in-pustulotic-arthro-osteitis-with-guselkumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.70321","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}